Programmed Cell Death Protein | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

69,549 results for “Programmed Cell Death Protein”

Trials

View all 46574 →

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

25 participants · First posted Dec 19, 2018

Tislelizumab in People With Colorectal Cancer

40 participants · First posted Jul 31, 2024

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

First posted Dec 20, 2018

Drugs

View all 5719 →

Programmed cell death protein 1 (PD-1)/PD-ligand-1 blockers (Hitgen)

Investigational

Ezabenlimab

Investigational

Serplulimab(Hetronifly)

Rx

Organizations

View all 191 →

Protein Sciences Corporation

United States

Gamida Cell

Israel

GAMIDA CELL INC.

United States

News

View all 17065 →

Chinese Researchers Discover Nicotinamide's Cardioprotective Effect Against PD-1 Inhibitor Toxicity

Advancements in Immune Checkpoint Inhibition for Hepatocellular Carcinoma Treatment

Minghui Pharmaceutical's MHB039A Shows Promise in Phase I Trial for Solid Tumors

Page 1 of 6955